SLBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.30200319812002E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.51900000022742E-07 |
Normal-vs-Stage2 |
7.643900E-04 |
Normal-vs-Stage3 |
1.53509982503408E-10 |
Normal-vs-Stage4 |
3.621600E-04 |
Stage1-vs-Stage2 |
5.202600E-01 |
Stage1-vs-Stage3 |
5.318700E-03 |
Stage1-vs-Stage4 |
4.290400E-01 |
Stage2-vs-Stage3 |
3.006200E-02 |
Stage2-vs-Stage4 |
9.650600E-01 |
Stage3-vs-Stage4 |
1.303530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.09399950104705E-10 |
Normal-vs-AfricanAmerican |
1.260399999925E-07 |
Normal-vs-Asian |
7.106100E-02 |
Caucasian-vs-AfricanAmerican |
4.429200E-01 |
Caucasian-vs-Asian |
8.647600E-01 |
AfricanAmerican-vs-Asian |
6.198800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.73659997493303E-09 |
Normal-vs-Female |
5.36059999722838E-08 |
Male-vs-Female |
7.612600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.87180000002607E-06 |
Normal-vs-Age(41-60Yrs) |
2.66390000058792E-08 |
Normal-vs-Age(61-80Yrs) |
6.63540000722662E-10 |
Normal-vs-Age(81-100Yrs) |
3.636600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.061200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.415000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.966800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.180200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.935400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.548800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.560500E-02 |
Normal-vs-Grade 2 |
1.9984999999334E-07 |
Normal-vs-Grade 3 |
9.59760049212832E-10 |
Normal-vs-Grade 4 |
3.581400E-04 |
Grade 1-vs-Grade 2 |
6.068200E-01 |
Grade 1-vs-Grade 3 |
1.941650E-01 |
Grade 1-vs-Grade 4 |
7.168600E-01 |
Grade 2-vs-Grade 3 |
4.097800E-02 |
Grade 2-vs-Grade 4 |
8.208000E-01 |
Grade 3-vs-Grade 4 |
2.119800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.26819999946015E-07 |
Normal-vs-ccB subtype |
1.1222000000366E-06 |
ccA subtype-vs-ccB subtype |
7.851600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.8509999633618E-09 |
Normal-vs-N1 |
5.746000E-02 |
N0-vs-N1 |
4.176200E-01 |
|
|